Clinical Trial Update: Inflammatory Response to Hydroxyurea Therapy in Sickle Cell Disease

View source ↗

Summary

A completed clinical trial update from Paris hospitals reports on inflammatory responses observed in sickle cell disease patients treated with hydroxyurea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sickle Cell Disease | Status: COMPLETED